Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg.
BACKGROUND
Poor response is a major concern in public health surveys. In a population-based ORISCAV-LUX study carried out in Grand-Duchy of Luxembourg to assess the cardiovascular risk factors, the non-response rate was not negligible. The aims of the present work were: 1) to investigate the representativeness of study sample to the general population, and 2) to compare the known demographic and cardiovascular health-related profiles of participants and non-participants.


METHODS
For sample representativeness, the participants were compared to the source population according to stratification criteria (age, sex and district of residence). Based on complementary information from the "medical administrative database", further analysis was carried out to assess whether the health status affected the response rate. Several demographic and morbidity indicators were used in the univariate comparison between participants and non-participants.


RESULTS
Among the 4452 potentially eligible subjects contacted for the study, there were finally 1432 (32.2%) participants. Compared to the source population, no differences were found for gender and district distribution. By contrast, the youngest age group was under-represented while adults and elderly were over-represented in the sample, for both genders. Globally, the investigated clinical profile of the non-participants was similar to that of participants. Hospital admission and cardiovascular health-related medical measures were comparable in both groups even after controlling for age. The participation rate was lower in Portuguese residents as compared to Luxembourgish (OR = 0.58, 95% CI: 0.48-0.69). It was also significantly associated with the professional status (P < 0.0001). Subjects from the working class were less receptive to the study than those from other professional categories.


CONCLUSIONS
The 32.2% participation rate obtained in the ORISCAV-LUX survey represents the realistic achievable rate for this type of multiple-stage, nationwide, population-based surveys. It corresponds to the expected rate upon which the sample size was calculated. Given the absence of discriminating health profiles between participants and non-participants, it can be concluded that the response rate does not invalidate the results and allows generalizing the findings for the population.
Alkerwi
Ala'a
A
Centre de Recherche Public de la Santé, Centre d'Etudes en Santé, Grand-Duchy of Luxembourg. alaa.alkerwi@crp-sante.lu
Sauvageot
Nicolas
N
Couffignal
Sophie
S
Albert
Adelin
A
Lair
Marie-Lise
ML
Guillaume
Michèle
M
D000328:Adult; D001530:Belgium; D006302:Health Services Research; D006801:Humans; D007407:Interviews as Topic; D008875:Middle Aged; D010821:Physicians, Family / Q000523:psychology*; D019338:Polypharmacy; D012424:Rural Population; D014505:Urban Population
Eur J Epidemiol. 2001;17(11):991-9
12380710
Am J Public Health. 1989 Jul;79(7):887-8
2735480
Ann Epidemiol. 2004 Jul;14(6):437-41
15246333
Am J Prev Med. 1986 Jan-Feb;2(1):20-5
3453156
J Epidemiol Community Health. 1990 Dec;44(4):316-20
2277255
Eur J Epidemiol. 2010 Mar;25(3):163-72
20127393
Public Health. 1995 Jul;109(4):267-73
7667491
Age Ageing. 1998 Jan;27(1):35-40
9504364
J Public Health Dent. 2000 Spring;60(2):72-81
10929564
J Clin Epidemiol. 1988;41(11):1105-16
3204420
Am J Epidemiol. 1989 Dec;130(6):1088-100
2589302
Scand J Soc Med. 1988;16(2):101-4
3387934
Eur J Public Health. 2005 Oct;15(5):528-35
16051660
BMC Med Res Methodol. 2007 Nov 28;7:51
18045472
Ann Epidemiol. 2004 Sep;14(8):579-84
15350958
Am J Epidemiol. 2006 Feb 1;163(3):197-203
16339049
J Public Health Med. 1997 Jun;19(2):203-7
9243437
Mayo Clin Proc. 2007 Aug;82(8):933-8
17673061
Eur J Epidemiol. 2005;20(2):173-81
15792285
Am J Public Health. 1999 Aug;89(8):1228-31
10432911
Public Health. 2006 Apr;120(4):297-308
16364384
Int J Equity Health. 2004 May 6;3(1):3
15128460
BMC Public Health. 2010 Aug 10;10:468
20698957
BMJ. 2002 May 18;324(7347):1183
12016181
J Epidemiol Community Health. 1987 Dec;41(4):295-9
3455423
Am J Epidemiol. 2001 Aug 15;154(4):373-84
11495861
J Epidemiol Community Health. 1995 Feb;49(1):87-93
7707013
Am J Epidemiol. 1978 Nov;108(5):367-72
727205
Osteoporos Int. 1995;5(5):327-34
8800782
Am J Epidemiol. 2004 Jan 15;159(2):204-10
14718223
J Epidemiol Community Health. 1995 Apr;49(2):124-30
7798038
Ann Epidemiol. 1993 Jul;3(4):358-66
8275211
Am J Epidemiol. 2004 Jan 1;159(1):94-101
14693664
J Clin Epidemiol. 1996 Dec;49(12):1441-46
8970495
J Epidemiol Community Health. 1981 Dec;35(4):293-6
6461711
J R Coll Gen Pract. 1988 Feb;38(307):57-60
3204566
Can J Cardiol. 1998 Nov;14(11):1349-57
9854515
J Epidemiol Community Health. 1992 Dec;46(6):617-9
1494079
Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000008
17443629
Int J Epidemiol. 2000 Oct;29(5):793-8
11034958
Public Opin Q. 2000 Summer;64(2):125-48
10984330
Alcohol Alcohol. 2003 Mar-Apr;38(2):128-34
12634259
Public Opin Q. 2000 Winter;64(4):413-28
11171024
J Epidemiol Community Health. 1991 Sep;45(3):247-50
1836811
Eur Respir J. 1994 Dec;7(12):2139-45
7713194
J Epidemiol Community Health. 1992 Aug;46(4):455-9
1431726
Phys Ther. 1980 Aug;60(8):1026-32
7403278
Eur J Epidemiol. 2005;20(11):887-98
16284866